{
  "abstract": "Untreated obstructive sleep apnoea (OSA) is associated with a wide range of adverse health outcomes, including but not limited to cardiocerebrovascular disease, hypertension and cognitive impairment.1 Positive airway pressure (PAP) therapy remains the first-line treatment for moderate to severe OSA.1 2 However, approximately 10–25% of patients continue to exhibit residual sleep apnoea despite PAP therapy.3 Although several factors contribute to residual sleep apnoea, such as male sex, OSA severity, older age with more comorbidities and central apnoeas,3 4 the physiological mechanisms underlying residual sleep apnoea and the ability to predict it reliably prior to treatment initiation are not well established.",
  "authors": [
    {
      "affiliations": [
        "Icahn School of Medicine at Mount Sinai, New York, New York, USA"
      ],
      "name": "Li Zhou"
    },
    {
      "affiliations": [
        "Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA"
      ],
      "name": "Ankit Parekh"
    }
  ],
  "title": "Towards a better understanding of residual sleep apnoea: the role of quantitatively assessed ventilatory control instability",
  "uid": "6d93a4e9-fe01-5ea3-9712-60bd73245dde"
}